⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
EBS News
Emergent Biosolutions, Inc.
Biodefense Market Size to Reach USD 29.17 Billion by 2035 | SNS Insider
globenewswire.com
EBS
SIGA
NanoViricides Has Shipped NV-387 Oral Gummies Drug Product for Phase II Clinical Trial to DR Congo
accessnewswire.com
NNVC
GILD
SIGA
EBS
EBSCO Clinical Decisions and AWHONN Partner to Drive Clinical Excellence in Women's Health, Obstetric and Neonatal Nursing
prnewswire.com
EBS
Nearly 800 Gather for the 23rd Annual Latinas in Leadership Symposium; Civil Rights Icon Dolores Huerta Defines Leadership as "People Who Do the Work"
prnewswire.com
TJX
EBS
WBS
MASS
Victoria's Voice Foundation Marks National Naloxone Awareness Day on June 6
prnewswire.com
EBS
Emergent BioSolutions Supports Victoria’s Voice Foundation’s National Naloxone Awareness Day to Help Save Lives from Opioid Overdose
globenewswire.com
EBS
Emergent BioSolutions Receives $64.5 Million Contract Modification for BAT® [Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G) – (Equine)] to Support U.S. Biodefense Strategy
globenewswire.com
EBS
$94 Bn Vaccines Market Industry Trends and Global Forecasts, 2026-2035: 200+ Preventive Vaccines, Developed by Both Industry and Non-industry Players are Being Evaluated
globenewswire.com
EBS
NVAX
MRNA
PFE
Emergent BioSolutions to Participate in Upcoming Investor Conferences
globenewswire.com
EBS
Emergent BioSolutions Receives Saudi Food and Drug Authority Approval for ACAM2000® [Smallpox and Mpox (Vaccinia) Vaccine, Live]
globenewswire.com
EBS